DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Anafranil (Clomipramine) - Side Effect Reports to FDA

 
 



This is an index of side effect / adverse reaction reports (a.k.a. adverse event reports) related to Anafranil (Clomipramine) and submitted to the FDA during the sample period of about a year. The information is not vetted and should not be considered as verified clinical evidence.

Reports by Event Outcome

All Cases (60)
Death (1)
Life Threatening Events (7)

Reports by Reaction Type

Cytolytic Hepatitis (12)Sopor (10)Cholestasis (9)Liver Injury (8)Jaundice (7)Hepatic Failure (7)Condition Aggravated (7)Hepatic Cirrhosis (6)Alcoholic Liver Disease (6)Ascites (6)Suicide Attempt (6)Urticaria (5)

Below are a few examples of reports where side effects / adverse reactions may be related to Anafranil (Clomipramine). For a complete list or a specific selection of reports, please use the links above.

Possible Anafranil side effects in 73 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-08-24

Patient: 73 year old female

Reactions: Dermo-Hypodermitis, Fungal Oesophagitis, Shock Haemorrhagic, Cytolytic Hepatitis, Cholestasis, Necrotising Fasciitis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Aldactone
    Dosage: 50 mg, 1x/day
    Administration route: Oral
    End date: 2012-06-26

Anafranil
    Dosage: 75 mg, 1x/day
    Administration route: Oral
    Indication: Depression
    Start date: 2012-05-01
    End date: 2012-06-26

Levofloxacin
    Dosage: 500 mg, 2x/day
    Administration route: Oral
    Start date: 2012-05-25
    End date: 2012-06-26

Orbenin CAP
    Dosage: 3 g, 3x/day
    Start date: 2012-05-25
    End date: 2012-06-26

Other drugs received by patient: Humalog; Lyrica; Lasix; Oxycodone Hydrochloride; Ketoprofen; Penicillin G Sodium; Clindamycin HCL; Nexium; Prednisone TAB; Oxycontin; Glucophage



Possible Anafranil side effects in male

Reported by a health professional (non-physician/pharmacist) from Italy on 2012-08-24

Patient: male

Reactions: Dysarthria, Tachycardia, Snoring, Drug Abuse, Sopor

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Anafranil
    Indication: Drug Abuse
    Start date: 2012-07-13
    End date: 2012-07-13

Clonazepam
    Indication: Drug Abuse
    Start date: 2012-07-13
    End date: 2012-07-13

Haldol
    Indication: Drug Abuse
    Start date: 2012-07-13
    End date: 2012-07-13

Lantanon
    Indication: Drug Abuse
    Start date: 2012-07-13
    End date: 2012-07-13

Olanzapine
    Indication: Drug Abuse
    Start date: 2012-07-13
    End date: 2012-07-13

Trazodone HCL
    Indication: Drug Abuse
    Start date: 2012-07-13
    End date: 2012-07-13

Valproic Acid
    Indication: Drug Abuse
    Start date: 2012-07-13
    End date: 2012-07-13



Possible Anafranil side effects in male

Reported by a physician from Italy on 2012-08-22

Patient: male, weighing 80.0 kg (176.0 pounds)

Reactions: Hypotension, Multiple Drug Overdose, Self Injurious Behaviour, Sopor

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Anafranil
    Administration route: Oral
    Indication: Self Injurious Behaviour
    Start date: 2012-07-13
    End date: 2012-07-13

Clonazepam
    Administration route: Oral
    Indication: Self Injurious Behaviour
    Start date: 2012-07-13
    End date: 2012-07-13

Haloperidol Lactate
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-13
    End date: 2012-07-13

Lantanon
    Administration route: Oral
    Indication: Self Injurious Behaviour
    Start date: 2012-07-13
    End date: 2012-07-13

Olanzapine
    Administration route: Oral
    Indication: Self Injurious Behaviour
    Start date: 2012-07-13
    End date: 2012-07-13

Trazodone HCL
    Administration route: Oral
    Indication: Self Injurious Behaviour
    Start date: 2012-07-13
    End date: 2012-07-13

Valproate Sodium
    Administration route: Oral
    Indication: Self Injurious Behaviour
    Start date: 2012-07-13
    End date: 2012-07-13



Possible Anafranil side effects in 65 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-08-21

Patient: 65 year old female

Reactions: Urticaria, Hepatocellular Injury, Cholestasis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Anafranil
    Dosage: 150 mg, 1x/day
    Administration route: Oral
    Indication: Major Depression
    Start date: 2012-06-22

Avastin
    Dosage: unk
    Indication: Breast Cancer
    Start date: 2012-02-01
    End date: 2012-07-16

Chlorpromazine HCL
    Dosage: 200 drop(s)
    Administration route: Oral
    Indication: Major Depression
    Start date: 2012-06-20
    End date: 2012-06-28

Midodrine Hydrochloride
    Dosage: unk
    Administration route: Oral
    Indication: Orthostatic Hypotension
    Start date: 2012-06-22
    End date: 2012-07-16

Paclitaxel
    Dosage: unk
    Indication: Breast Cancer Recurrent
    Start date: 2012-02-01
    End date: 2012-07-16

Zofran
    Dosage: 8 mg, weekly
    Administration route: Oral
    Indication: Vomiting
    Start date: 2012-02-01
    End date: 2012-07-16

Zyprexa
    Dosage: 10 mg, 1x/day
    Administration route: Oral
    Indication: Major Depression
    Start date: 2012-06-28
    End date: 2012-07-16

Other drugs received by patient: Nexium



Possible Anafranil side effects in male

Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-08-20

Patient: male, weighing 70.0 kg (154.0 pounds)

Reactions: Hyponatraemia, Brain Oedema, Serotonin Syndrome

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Anafranil
    Dosage: 75 mg
    Administration route: Oral
    Indication: Depression
    Start date: 2012-07-10
    End date: 2012-07-17

Escitalopram
    Dosage: 20 mg
    Administration route: Oral
    Indication: Depression
    Start date: 2012-07-10
    End date: 2012-07-17

Other drugs received by patient: Lorazepam; Noctamide; Pravastatin



Possible Anafranil side effects in female

Reported by a consumer/non-health professional from France on 2012-08-16

Patient: female

Reactions: Cytolytic Hepatitis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Anafranil
    Dosage: 150 mg, unknown
    Administration route: Oral
    Indication: Major Depression
    Start date: 2012-06-22
    End date: 2012-07-04

Anafranil
    Dosage: 75 mg, unknown
    Administration route: Oral
    Start date: 2012-07-05

Anafranil
    Dosage: unk unk, unknown
    Start date: 2012-06-20
    End date: 2012-06-21

Avastin
    Dosage: 25 mg/ml, 1x/week
    Indication: Breast Cancer Recurrent
    Start date: 2012-02-01
    End date: 2012-07-16

Largactil / 00011902 /
    Dosage: 150 - 250 df 4% drops, unknown
    Administration route: Oral
    Indication: Major Depression
    Start date: 2012-06-20
    End date: 2012-06-28

Midodrine Hydrochloride
    Dosage: 15 mg (6 tablets), unknown
    Administration route: Oral
    Indication: Orthostatic Hypotension
    Start date: 2012-06-22
    End date: 2012-07-02

Midodrine Hydrochloride
    Dosage: 30 mg (12 tablets), unknown
    Administration route: Oral
    Start date: 2012-07-03
    End date: 2012-07-16

Ondansetron
    Dosage: 1 df, 1x/week
    Administration route: Oral
    Indication: Procedural Vomiting
    Start date: 2012-02-01
    End date: 2012-07-16

Taxol
    Dosage: 1 df, 1x/week
    Indication: Breast Cancer Recurrent
    Start date: 2012-02-01
    End date: 2012-07-16

Zyprexa
    Dosage: 10 mg, unknown
    Administration route: Oral
    Indication: Major Depression
    Start date: 2012-06-28
    End date: 2012-07-16

Other drugs received by patient: Corticosteroid NOS; Esomeprazole



Possible Anafranil side effects in male

Reported by a physician from Italy on 2012-08-16

Patient: male

Reactions: Drug Abuse, Sopor

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Anafranil
    Administration route: Oral
    Indication: Drug Abuse
    Start date: 2012-07-13
    End date: 2012-07-13

Clonazepam
    Administration route: Oral
    Indication: Drug Abuse
    Start date: 2012-07-13
    End date: 2012-07-13

Haldol
    Administration route: Oral
    Indication: Drug Abuse
    Start date: 2012-07-13
    End date: 2012-07-13

Lantanon
    Administration route: Oral
    Indication: Drug Abuse
    Start date: 2012-07-13
    End date: 2012-07-13

Olanzapine
    Administration route: Oral
    Indication: Drug Abuse
    Start date: 2012-07-13
    End date: 2012-07-13

Trazodone HCL
    Administration route: Oral
    Indication: Drug Abuse
    Start date: 2012-07-13
    End date: 2012-07-13

Valproate Sodium
    Administration route: Oral
    Indication: Drug Abuse
    Start date: 2012-07-13
    End date: 2012-07-13



Possible Anafranil side effects in male

Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-08-09

Patient: male, weighing 70.0 kg (154.0 pounds)

Reactions: Brain Oedema, Hyponatraemia, Serotonin Syndrome

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Anafranil
    Dosage: 75 mg
    Administration route: Oral
    Indication: Depression
    Start date: 2012-07-10
    End date: 2012-07-17

Escitalopram
    Dosage: 20 mg
    Administration route: Oral
    Indication: Depression
    Start date: 2012-07-10
    End date: 2012-07-17

Other drugs received by patient: Noctamide; Lorazepam; Pravastatin



Possible Anafranil side effects in 65 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-08-08

Patient: 65 year old female

Reactions: Hepatocellular Injury, Urticaria, Cholestasis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Anafranil
    Dosage: 150 mg, 1x/day
    Administration route: Oral
    Indication: Major Depression
    Start date: 2012-06-22

Avastin
    Dosage: unk
    Indication: Breast Cancer
    Start date: 2012-02-01
    End date: 2012-07-16

Chlorpromazine HCL
    Dosage: 200 drop(s)
    Administration route: Oral
    Indication: Major Depression
    Start date: 2012-06-20
    End date: 2012-06-28

Midodrine Hydrochloride
    Dosage: unk
    Administration route: Oral
    Indication: Orthostatic Hypotension
    Start date: 2012-06-22
    End date: 2012-07-16

Paclitaxel
    Dosage: unk
    Indication: Breast Cancer Recurrent
    Start date: 2012-02-01
    End date: 2012-07-16

Zofran
    Dosage: unk
    Administration route: Oral
    Indication: Vomiting
    Start date: 2012-02-01
    End date: 2012-07-16

Zyprexa
    Dosage: 10 mg, unk
    Administration route: Oral
    Indication: Major Depression
    Start date: 2012-06-28
    End date: 2012-07-16

Other drugs received by patient: Esomeprazole



Possible Anafranil side effects in 65 year old female

Reported by a physician from France on 2012-08-02

Patient: 65 year old female

Reactions: Cytolytic Hepatitis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Anafranil
    Start date: 2012-07-05

Anafranil
    Dosage: 25 mg/ 2 ml
    Indication: Major Depression
    Start date: 2012-06-20

Anafranil
    Administration route: Oral
    Start date: 2012-06-22

Avastin
    Indication: Breast Cancer
    End date: 2012-07-16

Chlorpromazine HCL
    Indication: Major Depression
    Start date: 2012-06-20
    End date: 2012-06-28

Midodrine Hydrochloride
    End date: 2012-07-16

Midodrine Hydrochloride
    Administration route: Oral
    Indication: Orthostatic Hypotension
    Start date: 2012-06-22

Taxol
    Indication: Breast Cancer Recurrent
    End date: 2012-07-16

Zofran
    Administration route: Oral
    Indication: Vomiting
    End date: 2012-07-16

Zyprexa
    Administration route: Oral
    Indication: Major Depression
    Start date: 2012-06-28
    End date: 2012-07-16



Possible Anafranil side effects in female

Reported by a physician from France on 2012-08-02

Patient: female

Reactions: Urticaria, Hepatocellular Injury, Cholestasis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Anafranil
    Dosage: 150mg per day
    Administration route: Oral
    Indication: Major Depression
    Start date: 2012-06-22

Avastin
    Dosage: 25mgml weekly
    Indication: Breast Cancer
    Start date: 2012-02-01
    End date: 2012-07-16

Chlorpromazine HCL
    Dosage: 200drop per day
    Administration route: Oral
    Indication: Major Depression
    Start date: 2012-06-20
    End date: 2012-06-28

Midodrine Hydrochloride
    Administration route: Oral
    Indication: Orthostatic Hypotension
    Start date: 2012-06-22
    End date: 2012-07-16

Taxol
    Indication: Breast Cancer Recurrent
    Start date: 2012-02-01
    End date: 2012-07-16

Zofran
    Dosage: 8mg weekly
    Administration route: Oral
    Indication: Vomiting
    Start date: 2012-02-01
    End date: 2012-07-16

Zyprexa
    Dosage: 10mg per day
    Administration route: Oral
    Indication: Major Depression
    Start date: 2012-06-28
    End date: 2012-07-16

Other drugs received by patient: Nexium; Corticoid



Possible Anafranil side effects in female

Reported by a consumer/non-health professional from Denmark on 2012-08-01

Patient: female

Reactions: Cytolytic Hepatitis

Drug(s) suspected as cause:
Anafranil
    Dosage: 150 mg, unknown
    Indication: Major Depression
    Start date: 2012-06-22
    End date: 2012-07-04

Anafranil
    Dosage: 75 mg, unknown
    Administration route: Oral
    Start date: 2012-07-05

Avastin
    Dosage: 1 df, 1x/week
    Indication: Breast Cancer
    Start date: 2012-02-01
    End date: 2012-07-16

Largactil / 00011901 /
    Dosage: 250 df, unknown (150-250 df 4% drops for oral use)
    Administration route: Oral
    Indication: Major Depression
    Start date: 2012-06-20
    End date: 2012-06-28

Midodrine Hydrochloride
    Dosage: 30 mg, unknown
    Administration route: Oral
    Start date: 2012-07-03
    End date: 2012-07-16

Midodrine Hydrochloride
    Dosage: 15 mg, unknown
    Administration route: Oral
    Indication: Orthostatic Hypotension
    Start date: 2012-06-22
    End date: 2012-07-02

Ondansetron
    Dosage: 1 df, 1x/week
    Indication: Procedural Vomiting
    Start date: 2012-02-01
    End date: 2012-07-16

Taxol
    Dosage: 1 df, 1x/week
    Indication: Breast Cancer
    Start date: 2012-02-01
    End date: 2012-07-16

Zyprexa
    Dosage: 10 mg, unknown
    Administration route: Oral
    Indication: Major Depression
    Start date: 2012-06-28
    End date: 2012-07-16

Other drugs received by patient: Esomeprazole; Corticosteroid NOS



Possible Anafranil side effects in 73 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-07-27

Patient: 73 year old female

Reactions: Dermo-Hypodermitis, Cytolytic Hepatitis, Cholestasis, Necrotising Fasciitis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Aldactone
    Dosage: 50 mg, 1x/day
    Administration route: Oral
    End date: 2012-06-26

Anafranil
    Dosage: 75 mg, 1x/day
    Administration route: Oral
    Indication: Depression
    Start date: 2012-05-01
    End date: 2012-06-26

Levofloxacin
    Dosage: 500 mg, 2x/day
    Administration route: Oral
    Start date: 2012-05-25
    End date: 2012-06-26

Orbenin CAP
    Dosage: 3 g, 3x/day
    Start date: 2012-05-25
    End date: 2012-06-26

Other drugs received by patient: Humalog; Ketoprofen; Oxycodone HCL; Penicillin G Sodium; Nexium; Lyrica; Clindamycin HCL; Glucophage; Prednisone TAB; Oxycontin; Lasix



Possible Anafranil side effects in 73 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-07-25

Patient: 73 year old female

Reactions: Cytolytic Hepatitis, Cholestasis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Aldactone
    Dosage: 50 mg, 1x/day
    Administration route: Oral
    End date: 2012-06-26

Anafranil
    Dosage: 75 mg, 1x/day
    Administration route: Oral
    Indication: Depression
    Start date: 2012-05-01
    End date: 2012-06-26

Levofloxacin
    Dosage: 500 mg, 2x/day
    Administration route: Oral
    Start date: 2012-05-25
    End date: 2012-06-26

Orbenin CAP
    Dosage: 3 g, 3x/day
    Start date: 2012-05-25
    End date: 2012-06-26

Other drugs received by patient: Lasix; Nexium; Clindamycin HCL; Oxycodone HCL; Prednisone TAB; Humalog; Lyrica; Ketoprofen; Penicillin G Sodium; Oxycontin; Glucophage



Possible Anafranil side effects in 38 year old male

Reported by a physician from Italy on 2012-07-23

Patient: 38 year old male, weighing 80.0 kg (176.0 pounds)

Reactions: Hypotension, Multiple Drug Overdose, Self Injurious Behaviour, Sopor

Drug(s) suspected as cause:
Anafranil
    Administration route: Oral
    Indication: Self Injurious Behaviour
    Start date: 2012-07-13
    End date: 2012-07-13

Clonazepam
    Administration route: Oral
    Indication: Self Injurious Behaviour
    Start date: 2012-07-13
    End date: 2012-07-13

Haldol
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-13
    End date: 2012-07-13

Lantanon
    Administration route: Oral
    Indication: Self Injurious Behaviour
    Start date: 2012-07-13
    End date: 2012-07-13

Olanzapine
    Administration route: Oral
    Indication: Self Injurious Behaviour
    Start date: 2012-07-13
    End date: 2012-07-13

Trazodone HCL
    Administration route: Oral
    Indication: Self Injurious Behaviour
    Start date: 2012-07-13
    End date: 2012-07-13

Valproate Sodium
    Administration route: Oral
    Indication: Self Injurious Behaviour
    Start date: 2012-07-13
    End date: 2012-07-13



Possible Anafranil side effects in 67 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-07-18

Patient: 67 year old female

Reactions: Agitation, Confusional State, Hyponatraemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Anafranil
    Dosage: 150 mg, 1x/day
    Administration route: Oral
    Start date: 2011-03-25

Atorvastatin
    Dosage: 20 mg, 1x/day
    Administration route: Oral
    Start date: 2010-12-15

Imovane
    Dosage: 7.5 mg, 1x/day
    Administration route: Oral
    Start date: 2011-11-24

Oxazepam
    Dosage: 10 mg, 1x/day
    Administration route: Oral
    Start date: 2011-01-28

Quetiapine Fumarate
    Dosage: 300 mg, 1x/day
    Administration route: Oral
    Start date: 2011-11-29



Possible Anafranil side effects in female

Reported by a physician from France on 2012-07-18

Patient: female

Reactions: Agitation, Confusional State, Hyponatraemia, Urinary Retention

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Anafranil
    Administration route: Oral
    Start date: 2011-03-25

Atorvastatin
    Administration route: Oral
    Start date: 2010-12-15

Imovane
    Administration route: Oral
    Start date: 2011-11-24

Oxazepam
    Administration route: Oral
    Start date: 2011-01-28

Quetiapine Fumarate
    Administration route: Oral
    Start date: 2011-11-29



Possible Anafranil side effects in 24 year old male

Reported by a consumer/non-health professional from Brazil on 2012-07-04

Patient: 24 year old male, weighing 74.0 kg (162.8 pounds)

Reactions: Attention Deficit / Hyperactivity Disorder

Drug(s) suspected as cause:
Anafranil
    Dosage: 3 df, qd
    Indication: Anxiety

Trileptal
    Dosage: 1 df, tid
    Indication: Bipolar Disorder



Possible Anafranil side effects in male

Reported by a health professional (non-physician/pharmacist) from France on 2012-07-02

Patient: male

Reactions: Hyperkalaemia, Urinary Retention, Constipation, Faecaloma, Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Anafranil
    Dosage: 20 mg
    Administration route: Oral
    Indication: Depression

Spiriva
    Dosage: one puff on morning
    Indication: Chronic Obstructive Pulmonary Disease

Other drugs received by patient: Aminophylline; Alfuzosin HCL; Forlax; Aspirin



Possible Anafranil side effects in male

Reported by a physician from Germany on 2012-06-22

Patient: male

Reactions: Delirium

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Anafranil
    Administration route: Oral
    Start date: 2012-02-04
    End date: 2012-02-07

Anafranil
    Administration route: Oral
    Start date: 2012-02-01
    End date: 2012-02-01

Anafranil
    Administration route: Oral
    Start date: 2012-02-02
    End date: 2012-02-03

Anafranil
    Administration route: Oral
    Start date: 2012-02-08
    End date: 2012-02-21

Anafranil
    Administration route: Oral
    Start date: 2012-02-22
    End date: 2012-02-24

Lithium Carbonate
    Administration route: Oral
    Start date: 2011-11-01
    End date: 2012-02-20

Lithium Carbonate
    Administration route: Oral
    Start date: 2012-02-23

Mirtazapine
    Administration route: Oral
    Start date: 2011-11-01
    End date: 2012-02-23

Seroquel XR
    Administration route: Oral
    Start date: 2012-02-02
    End date: 2012-02-27

Seroquel XR
    Administration route: Oral
    Start date: 2011-11-01
    End date: 2012-02-01

Seroquel XR
    Administration route: Oral
    Start date: 2012-02-28

Other drugs received by patient: Clonazepam; Clonazepam; Allopurinol; Clonazepam



Possible Anafranil side effects in male

Reported by a consumer/non-health professional from United States on 2012-06-21

Patient: male, weighing 80.3 kg (176.6 pounds)

Reactions: Psychotic Disorder, Drug Interaction

Drug(s) suspected as cause:
Anafranil
    Dosage: 1 tablet daily oral
    Administration route: Oral
    Indication: Obsessive-Compulsive Disorder
    Start date: 1990-01-01
    End date: 1991-01-01

Prozac
    Dosage: 1 tablet daily oral
    Administration route: Oral
    Indication: Obsessive-Compulsive Disorder
    Start date: 1989-01-01

Prozac
    Dosage: 1 tablet daily oral
    Administration route: Oral
    Indication: Obsessive-Compulsive Disorder
    Start date: 1991-01-01

Other drugs received by patient: Chlorpromazine HCL



Possible Anafranil side effects in female

Reported by a consumer/non-health professional from Brazil on 2012-06-21

Patient: female

Reactions: Drug Dependence

Drug(s) suspected as cause:
Anafranil
    Dosage: 1 df, qd

Formoterol Fumarate
    Dosage: 1 df, bid

Naphazoline Hydrochloride
    Dosage: 1 df, qd

Slow-K
    Dosage: 1 df, qid



Possible Anafranil side effects in male

Reported by a physician from Japan on 2012-06-14

Patient: male, weighing 78.0 kg (171.6 pounds)

Reactions: Road Traffic Accident, Contusion, Somnolence, Erythema, Haemorrhage Subcutaneous

Drug(s) suspected as cause:
Anafranil
    Administration route: Oral
    Indication: Depression
    Start date: 2011-04-14
    End date: 2011-07-14

Anafranil
    Administration route: Oral
    Indication: Pain
    Start date: 2011-04-14
    End date: 2011-07-14

Anafranil
    Administration route: Oral
    Indication: Fibromyalgia
    Start date: 2011-04-14
    End date: 2011-07-14

Anafranil
    Administration route: Oral
    Indication: Sleep Disorder Therapy
    Start date: 2011-04-14
    End date: 2011-07-14

Codeine Phosphate
    Administration route: Oral
    Start date: 2009-09-28

Codeine Phosphate
    Administration route: Oral
    Start date: 2011-02-22

Codeine Phosphate
    Administration route: Oral
    Start date: 2010-08-20

Codeine Phosphate
    Administration route: Oral
    Indication: Pain
    Start date: 2010-10-05

Codeine Phosphate
    Administration route: Oral
    Start date: 2011-04-19
    End date: 2011-06-13

Codeine Phosphate
    Administration route: Oral
    Start date: 2009-12-01

Depas
    Administration route: Oral
    Indication: Fibromyalgia

Depas
    Administration route: Oral
    Indication: Sleep Disorder Therapy

Depas
    Administration route: Oral
    Indication: Depression

Depas
    Administration route: Oral
    Indication: Pain

Fentanyl-100
    Indication: Pain
    Start date: 2011-06-14
    End date: 2011-07-20

Paxil
    Administration route: Oral
    Indication: Pain

Paxil
    Administration route: Oral
    Indication: Sleep Disorder Therapy

Paxil
    Administration route: Oral
    Indication: Fibromyalgia

Paxil
    Administration route: Oral
    Indication: Depression

Silece
    Administration route: Oral
    Indication: Fibromyalgia

Silece
    Administration route: Oral
    Indication: Pain

Silece
    Administration route: Oral
    Indication: Sleep Disorder Therapy

Silece
    Administration route: Oral
    Indication: Depression

Tetramide
    Administration route: Oral
    Indication: Sleep Disorder Therapy
    Start date: 2011-07-04

Tetramide
    Administration route: Oral
    Indication: Pain
    Start date: 2011-07-04

Tetramide
    Administration route: Oral
    Indication: Depression
    Start date: 2011-07-04

Tetramide
    Administration route: Oral
    Indication: Fibromyalgia
    Start date: 2011-07-04

Other drugs received by patient: Omeprazole; Celebrex; Mexitil; Bisoprolol Fumarate; Primperan TAB



Possible Anafranil side effects in male

Reported by a physician from Japan on 2012-06-05

Patient: male, weighing 78.0 kg (171.6 pounds)

Reactions: Road Traffic Accident, Contusion, Drug Intolerance, Somnolence

Drug(s) suspected as cause:
Anafranil
    Administration route: Oral
    Indication: Pain
    Start date: 2011-04-14
    End date: 2011-07-14

Codeine Phosphate
    Administration route: Oral
    Start date: 2011-07-05
    End date: 2011-07-11

Codeine Phosphate
    Administration route: Oral
    Start date: 2009-09-01

Codeine Phosphate
    Administration route: Oral
    Indication: Pain
    Start date: 2011-06-21
    End date: 2011-06-27

Codeine Phosphate
    Administration route: Oral
    Start date: 2011-06-28
    End date: 2011-07-04

Codeine Phosphate
    Administration route: Oral
    Start date: 2011-06-14
    End date: 2011-06-20

Depas
    Administration route: Oral
    Indication: Pain

Fentanyl-100
    Indication: Pain
    Start date: 2011-06-14
    End date: 2011-07-20

Paxil
    Administration route: Oral
    Indication: Pain

Silece
    Administration route: Oral
    Indication: Pain

Tetramide
    Administration route: Oral
    Indication: Pain
    Start date: 2011-07-04

Other drugs received by patient: Omeprazole; Primperan TAB; Bisoprolol Fumarate; Mexitil; Celebrex



Possible Anafranil side effects in 76 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-05-15

Patient: 76 year old female, weighing 60.5 kg (133.1 pounds)

Reactions: Orthostatic Hypotension, Fall

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Anafranil
    Administration route: Oral
    End date: 2011-04-26

Lasix
    Administration route: Oral
    End date: 2011-04-24



Possible Anafranil side effects in male

Reported by a physician from Japan on 2012-05-04

Patient: male, weighing 78.0 kg (171.6 pounds)

Reactions: Contusion, Road Traffic Accident, Drug Intolerance, Somnolence

Drug(s) suspected as cause:
Anafranil
    Administration route: Oral
    Indication: Pain
    Start date: 2011-04-14
    End date: 2011-07-14

Codeine Phosphate
    Administration route: Oral
    Start date: 2011-07-05
    End date: 2011-07-11

Codeine Phosphate
    Administration route: Oral
    Start date: 2011-06-28
    End date: 2011-07-04

Codeine Phosphate
    Administration route: Oral
    Start date: 2009-09-01

Codeine Phosphate
    Administration route: Oral
    Start date: 2011-06-14
    End date: 2011-06-20

Codeine Phosphate
    Administration route: Oral
    Indication: Pain
    Start date: 2011-06-21
    End date: 2011-06-27

Depas
    Administration route: Oral
    Indication: Pain

Fentanyl-100
    Indication: Pain
    Start date: 2011-06-14
    End date: 2011-07-20

Paxil
    Administration route: Oral
    Indication: Pain

Silece
    Administration route: Oral
    Indication: Pain

Tetramide
    Administration route: Oral
    Indication: Pain
    Start date: 2011-07-04

Other drugs received by patient: Bisoprolol Fumarate; Omeprazole; Primperan TAB; Celebrex; Mexitil



Possible Anafranil side effects in 52 year old male

Reported by a consumer/non-health professional from Italy on 2012-04-18

Patient: 52 year old male

Reactions: Jaundice, Liver Injury, Cytolytic Hepatitis, Blood Albumin Decreased, Hepatic Failure, Condition Aggravated, Alcoholic Liver Disease, Ascites, Hepatosplenomegaly, Hepatic Cirrhosis, Prothrombin Level Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Alprazolam
    Dosage: 0.25 mg, tid
    Administration route: Oral
    Indication: Mental Disorder
    End date: 2012-01-21

Anafranil
    Dosage: 0.25 mg, tid
    Administration route: Oral
    Indication: Depression
    Start date: 2012-01-01
    End date: 2012-01-21

Escitalopram
    Dosage: 20 mg, daily
    Administration route: Oral
    Indication: Depression
    Start date: 2011-10-01
    End date: 2012-01-01

Rasilez HCT
    Dosage: 1 df, daily
    Administration route: Oral
    Indication: Hypertension
    End date: 2012-01-21

Zyprexa
    Dosage: 5 mg, daily
    Administration route: Oral
    Indication: Depression
    Start date: 2011-11-23
    End date: 2012-01-05

Other drugs received by patient: Prazepam



Possible Anafranil side effects in 52 year old male

Reported by a health professional (non-physician/pharmacist) from Italy on 2012-04-18

Patient: 52 year old male

Reactions: Jaundice, Liver Injury, Cytolytic Hepatitis, Condition Aggravated, Blood Albumin Decreased, Hepatic Failure, Alcoholic Liver Disease, Ascites, Hepatosplenomegaly, Hepatic Cirrhosis, Prothrombin Level Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Alprazolam
    Dosage: 0.25 mg, tid
    Administration route: Oral
    Indication: Mental Disorder
    End date: 2012-01-21

Anafranil
    Dosage: 0.25 mg, tid
    Administration route: Oral
    Indication: Depression
    Start date: 2012-01-01
    End date: 2012-01-21

Escitalopram
    Dosage: 20 mg, daily
    Administration route: Oral
    Indication: Depression
    Start date: 2011-10-01
    End date: 2012-01-01

Rasilez HCT
    Dosage: 1 df, daily
    Administration route: Oral
    Indication: Hypertension
    End date: 2012-01-21

Zyprexa
    Dosage: 5 mg, daily
    Administration route: Oral
    Indication: Depression
    Start date: 2011-11-23
    End date: 2012-01-05

Other drugs received by patient: Prazepam



Possible Anafranil side effects in 52 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-04-12

Patient: 52 year old male

Reactions: Liver Injury, Jaundice, Cytolytic Hepatitis, Condition Aggravated, Hepatic Failure, Blood Albumin Decreased, Prothrombin Time Prolonged, Alcoholic Liver Disease, Ascites, Hepatic Enzyme Increased, Gynaecomastia, Spider Vein, Hepatomegaly, Hepatosplenomegaly, Hepatic Cirrhosis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Alprazolam
    Dosage: 0.25 mg, tid
    End date: 2012-01-21

Anafranil
    Dosage: 37.5 mg, qd
    End date: 2012-01-21

Escitalopram
    Dosage: 20 mg, qd
    Indication: Depression
    End date: 2012-01-01

Rasilez HCT
    Dosage: 1 df, unk
    Administration route: Oral
    Indication: Hypertension
    End date: 2012-01-21

Zyprexa
    Dosage: 5 mg, qd
    Indication: Depression
    End date: 2012-01-05

Other drugs received by patient: Prazepam



Possible Anafranil side effects in 52 year old male

Reported by a physician from France on 2012-04-12

Patient: 52 year old male

Reactions: Liver Injury, Jaundice, Cytolytic Hepatitis, Condition Aggravated, Hepatic Failure, Alcoholic Liver Disease, Ascites, Hepatic Enzyme Increased, Gynaecomastia, Hepatomegaly, Hepatic Cirrhosis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Alprazolam
    Dosage: 0.25 mg, tid
    End date: 2012-01-21

Anafranil
    Dosage: 37.5 mg, qd
    End date: 2012-01-21

Escitalopram Oxalate
    Dosage: 20 mg, qd
    Indication: Depression
    End date: 2012-01-01

Rasilez HCT
    Dosage: 1 df, unk
    Administration route: Oral
    Indication: Hypertension
    End date: 2012-01-21

Zyprexa
    Dosage: 5 mg, qd
    Indication: Depression
    End date: 2012-01-05

Other drugs received by patient: Prazepam

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017